
Kelvin Health 2022 Recap
The year 2022 proved to be very dynamic and rewarding for Kelvin Health. We focused deeply on the CVD indications; achieved significant progress in further
KELVIN HEALTH
Kelvin Health is a clinical decision support tool utilizing a mobile thermal imaging camera that captures the heat of the body, segments the thermal image, and applies artificial intelligence to detect anomalies related to vascular conditions and some inflammatory and oncology diseases.
Q&A Series with prof. Ivo Petrov MD
Q&A Series with prof. Ivo Petrov MD
Q&A Series with prof. Ivo Petrov MD
Q&A Series with prof. Ivo Petrov MD
Q&A Series with prof. Ivo Petrov MD
Q&A Series with prof. Ivo Petrov MD
Q&A Series with prof. Ivo Petrov MD
Q&A Series with prof. Ivo Petrov MD
Q&A Series with prof. Ivo Petrov MD
The utilization of Kelvin Health significantly reduces the risk of undercare by providing a cost and time efficient screening and monitoring approach. It leads to wider, earlier, and more relevant intervention by health care providers and pharma companies.
Kelvin Health uses a mobile thermal imaging camera that captures the heat of the body, segments the thermal image, and applies artificial intelligence to detect anomalies related to vascular conditions.
The thermal camera can capture the heat of the body even under layers of body tissues. If something is wrong with the thermal footprint of the body there are a limited number of potential reasons, such as changes in the vascular system that our AI can recognize.
Applying this scanning process frequently naturally increases the precision of the method.
Portable, widely accessible and personalized
Appropriate for frequent application to every demographic group
Allowing remote self-application, then notifying the doctor
Causing minimal physical, logistical and financial discomfort
Constantly evolving thanks to big data and machine learning
More than 202 million people worldwide suffer from peripheral arterial disease (PAD) and more than 40% of them are asymptomatic.
The hard access to frequent screening and monitoring leads to complications such as critical limb ischemia (CLI) that have very negative prognosis including major amputation or even death.
You can see an angiography demonstrating that the blood flow of the right leg is blocked at the knee level. The same is true about the right leg, so both legs are not well supplied with blood below the knee line.
Kelvin Health’s thermogram in the middle leads to the same conclusion, as the lower parts of both legs are much colder than the upper.
We have implemented the software backbone, the machine learning toolchain and a mobile app for research data collection, currently used in multiple hospitals across Europe, including one of the leading cardiology clinics in South East Europe.
Our current focus is on extending the R&D collaborations, training precise ML models, protecting IPR, and getting regulatory approvals.
We believe that there is a unique opportunity to help hundreds of millions of patients and their families, thanks to our expertise in machine learning, the creation of a unique dataset with our R&D partners and taking advantage of the continuously growing trend towards personalized healthcare and telemedicine.
If you believe that a true unicorn is a company that positively touches the lives of billions of people we’ll be happy to have you as a partner on this journey!
We’ll be happy to have you as a partner on this journey to help hundreds of millions of patients and their families, thanks to our expertise in machine learning, the unique medical-grade dataset we are creating, and the rise of precision medicine, personalized healthcare, and telemedicine.
The year 2022 proved to be very dynamic and rewarding for Kelvin Health. We focused deeply on the CVD indications; achieved significant progress in further
Our CEO Georgi Kadrev was invited to present Kelvin Health’s mission and vision of precise and accessible rapid diagnostics of socially significant diseases, in the the company of 14 other heavily funded startups.
Our medical director Prof. Ivo Petrov took part in VEITH Symposium New York ’22 – one of the most important events in the world for vascular specialists.